A new report from Reportlinker.com, "U.S. Disposable Medical Supplies Market," says that demand for disposable medical supplies is forecast to increase 4.3 percent annually to $46.7 billion in 2016. An expanding volume of patient care activity spurred by aging demographic patterns, a rising incidence of diseases and disorders, and the extension of health insurance coverage by the Affordable Care Act of 2010 will promote growth.
Demand for disposable medical supplies will also build upward momentum as hospitals, outpatient facilities and other healthcare establishments adopt stricter infection prevention safeguards to meet stronger standards. Healthcare cost containment pressures will remain the key moderating influence on growth in the U.S. disposable medical supplies market. Hospitals and other medical providers will become increasingly price sensitive in purchasing products as public and private health insurance concerns tighten restrictions on fees paid for patient procedures.
Drug delivery devices will remain the largest and fastest growing group of disposable medical supplies. Growth will reflect an expanding number of chronic care patients who require surgery or continuous therapy. This trend, coupled with the introduction of new higher value-added, safety-enhanced products, will boost demand for several single-use products, including prefillable syringes and inhalers, intravenous catheters, oxygen therapy disposables, hemodialysis bloodlines and peritoneal dialysis kits.
Demand for wound management supplies will benefit from tissue sealants and adhesives composed of polymers and bioengineered substances, along with foam, alginate, collagen and growth factor wound dressings, to post the fastest gains based on performance advantages in the healing of surgical incisions and treatment of moderate-to-severe lacerations, respectively. Conversely, demand for bandages will expand at a below average pace due to limited pricing flexibility and the overall lack of proprietary types. First aid kits will fare the best among the products in this group, building momentum from trends that promote selftreatment. Gains in less invasive surgery will weaken the overall market for traditional suture and staple wound closures.
Class IV surgical drapes and gowns will post the strongest sales gains among nonwoven medical textiles as surgical infection prevention safeguards are upgraded by hospitals and ambulatory surgery centers. Disposable face masks will also fare well in the marketplace, benefiting from routine use by medical providers in virtually all direct contact patient procedures. New enhanced absorbent, odor neutralized undergarments and shields will see the fastest gains in demand among incontinence products due to comfort and protection advantages. Among other disposable medical supplies, blood glucose test strips; surgical, diagnostic and urinary catheters; biological sterilization indicators; and medical waste disposal products will realize the fastest growth in demand. An expanding number of diabetics engaging in selftesting will boost sales of blood glucose test strips. A rising prevalence of heart conditions will promote the increasing use of surgical and diagnostic catheters, with devices for angioplasty and angiography posting the fastest demand gains.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.